Neither the Securities and Exchange Commission (the “SEC”)
nor any state securities commission has approved or disapproved of the notes or passed upon the accuracy or the adequacy of this pricing
supplement or the accompanying product supplement, underlying supplement, prospectus supplement and prospectus. Any representation to
the contrary is a criminal offense.
Pricing supplement to product supplement no. 4-II dated
November 4, 2020, underlying supplement no. 1-II dated November 4, 2020
and the prospectus and prospectus supplement, each dated April 8, 2020
Key Terms
Issuer:
JPMorgan Chase Financial Company LLC, an indirect, wholly owned finance subsidiary of JPMorgan Chase & Co.
Guarantor:
JPMorgan Chase & Co.
Indices:
The S&P 500® Index (Bloomberg ticker: SPX), the Russell 2000® Value Index (Bloomberg ticker: RUJ) and
the Russell 1000® Growth Index (Bloomberg ticker: RLG)
Contingent
Interest Payments: If the notes have not been previously redeemed early and the closing level of each Index on any Review Date
is greater than or equal to its Interest Barrier, you will receive on the applicable Interest Payment Date for each $1,000 principal amount
note a Contingent Interest Payment equal to at least $6.25 (equivalent to a Contingent Interest Rate of at least 7.50% per annum, payable
at a rate of at least 0.625% per month) (to be provided in the pricing supplement), plus any previously unpaid Contingent Interest
Payments for any prior Review Dates.
If the Contingent Interest Payment is not paid on any Interest Payment
Date, that unpaid Contingent Interest Payment will be paid on a later Interest Payment Date if the closing level of each Index on the
Review Date related to that later Interest Payment Date is greater than or equal to its Interest Barrier. You will not receive any unpaid
Contingent Interest Payments if the closing level of any Index on each subsequent Review Date is less than its Interest Barrier.
Contingent
Interest Rate: At least 7.50% per annum, payable at a rate of at least 0.625% per month (to
be provided in the pricing supplement)
Interest Barrier: With
respect to each Index, 75.00% of its Initial Value
Buffer
Threshold: With respect to each Index, 70.00% of its Initial Value
Buffer
Amount: 30.00%
Downside
Leverage Factor: An amount equal to 1 / (1 – Buffer Amount), which is 1.42857
Pricing
Date: On or about March 24, 2023
Original
Issue Date (Settlement Date): On or about March 29, 2023
Review
Dates*: April 24, 2023, May 24, 2023, June 26, 2023, July 24, 2023, August 24, 2023, September 25, 2023, October 24, 2023,
November 24, 2023, December 26, 2023, January 24, 2024, February 26, 2024 and March 25, 2024 (final Review Date)
Interest
Payment Dates*: April 27, 2023, May 30, 2023, June 29, 2023, July 27, 2023, August 29, 2023, September 28, 2023, October 27,
2023, November 29, 2023, December 29, 2023, January 29, 2024, February 29, 2024 and the Maturity Date
Maturity
Date*: March 28, 2024
* Subject to postponement in the event of a market disruption
event and as described under “General Terms of Notes — Postponement of a Determination Date — Notes Linked to Multiple
Underlyings” and “General Terms of Notes — Postponement of a Payment Date” in the accompanying product supplement |
Early Redemption:
We, at our election, may redeem the notes early, in whole but not in
part, on any of the Interest Payment Dates (other than the first through fifth and final Interest Payment Date) at a price, for each $1,000
principal amount note, equal to (a) $1,000 plus (b) the Contingent Interest Payment, if any, applicable to the immediately preceding
Review Date plus (c) if the Contingent Interest Payment applicable to the immediately preceding Review Date is payable, any previously
unpaid Contingent Interest Payments for any prior Review Dates. If we intend to redeem your notes early, we will deliver notice to The
Depository Trust Company, or DTC, at least three business days before the applicable Interest Payment Date on which the notes are redeemed
early.
Payment at Maturity:
If the notes have not been redeemed early and the Final Value of each Index
is greater than or equal to its Buffer Threshold, you will receive a cash payment at maturity, for each $1,000 principal amount note,
equal to (a) $1,000 plus (b) the Contingent Interest Payment, if any, applicable to the final Review Date plus (c) if the
Contingent Interest Payment applicable to the final Review Date is payable, any previously unpaid Contingent Interest Payments for any
prior Review Dates.
If the notes have not been redeemed early and the Final Value of any Index
is less than its Buffer Threshold, your payment at maturity per $1,000 principal amount note will be calculated as follows:
$1,000 + [$1,000 × (Least Performing Index Return
+ Buffer Amount) × Downside Leverage Factor]
If the notes have not been redeemed early and the Final Value of any Index
is less than its Buffer Threshold, you will lose some or all of your principal amount at maturity.
Least Performing Index: The
Index with the Least Performing Index Return
Least Performing Index Return: The
lowest of the Index Returns of the Indices
Index Return:
With respect to each Index,
(Final Value – Initial Value)
Initial Value
Initial
Value: With respect to each Index, the closing level of that Index on the Pricing Date
Final
Value: With respect to each Index, the closing level of that Index on the final Review Date
|
PS-1
| Structured Investments
Callable Contingent Interest Notes Linked to the Least Performing
of the S&P 500® Index, the Russell 2000® Value Index and the Russell 1000® Growth Index |
|
Payments in Connection with the First
through Fifth Review Dates
Payments in Connection with Review Dates
(Other than the First through Fifth and Final Review Dates)
PS-2
| Structured Investments
Callable Contingent Interest Notes Linked to the Least Performing
of the S&P 500® Index, the Russell 2000® Value Index and the Russell 1000® Growth Index |
|
Payment at Maturity If the Notes Have
Not Been Redeemed Early
PS-3
| Structured Investments
Callable Contingent Interest Notes Linked to the Least Performing
of the S&P 500® Index, the Russell 2000® Value Index and the Russell 1000® Growth Index |
|
Total Contingent Interest Payments
The table below illustrates the hypothetical total Contingent
Interest Payments per $1,000 principal amount note over the term of the notes based on a hypothetical Contingent Interest Rate of 7.50%
per annum, depending on how many Contingent Interest Payments are made prior to early redemption or maturity. The actual Contingent Interest
Rate will be provided in the pricing supplement and will be at least 7.50% per annum.
Number of Contingent
Interest Payments |
Total Contingent Interest
Payments |
12 |
$75.00 |
11 |
$68.75 |
10 |
$62.50 |
9 |
$56.25 |
8 |
$50.00 |
7 |
$43.75 |
6 |
$37.50 |
5 |
$31.25 |
4 |
$25.00 |
3 |
$18.75 |
2 |
$12.50 |
1 |
$6.25 |
0 |
$0.00 |
PS-4
| Structured Investments
Callable Contingent Interest Notes Linked to the Least Performing
of the S&P 500® Index, the Russell 2000® Value Index and the Russell 1000® Growth Index |
|
Hypothetical Payout Examples
The following examples illustrate payments on the notes
linked to three hypothetical Indices, assuming a range of performances for the hypothetical Least Performing Index on the Review Dates.
The hypothetical payments set forth below assume the
following:
| · | the notes have not been redeemed early; |
| · | an Initial Value for the Least Performing Index of 100.00; |
| · | an Interest Barrier for the Least Performing Index of 75.00 (equal to 75.00% of its hypothetical Initial Value); |
| · | a Buffer Threshold for the Least Performing Index of 70.00 (equal to 70.00% of its hypothetical Initial Value); |
| · | a Buffer Amount of 30.00%; |
| · | a Downside Leverage Factor of 1.42857; and |
| · | a Contingent Interest Rate of 7.50% per annum (payable at a rate of 0.625% per month). |
The hypothetical Initial Value of the Least Performing
Index of 100.00 has been chosen for illustrative purposes only and may not represent a likely actual Initial Value of any Index. The actual
Initial Value of each Index will be the closing level of that Index on the Pricing Date and will be provided in the pricing supplement.
For historical data regarding the actual closing levels of each Index, please see the historical information set forth under “The
Indices” in this pricing supplement.
Each hypothetical payment set forth below is for illustrative
purposes only and may not be the actual payment applicable to a purchaser of the notes. The numbers appearing in the following examples
have been rounded for ease of analysis.
Example 1 — Notes have NOT been redeemed early
and the Final Value of the Least Performing Index is greater than or equal to its Trigger Value and its Buffer Threshold.
Date |
Closing Level of Least
Performing Index |
Payment (per $1,000 principal amount note) |
First Review Date |
95.00 |
$6.25 |
Second Review Date |
85.00 |
$6.25 |
Third through Eleventh Review Dates |
Less than Interest Barrier |
$0 |
Final Review Date |
90.00 |
$1,062.50 |
|
Total Payment |
$1,075.00 (7.50% return) |
Because the notes have not been redeemed early and
the Final Value of the Least Performing Index is greater than or equal to its Buffer Threshold, the payment at maturity, for each $1,000
principal amount note, will be $1,062.50 (or $1,000 plus the Contingent Interest Payment applicable to the final Review Date plus
the unpaid Contingent Interest Payments for any prior Review Dates). When added to the Contingent Interest Payments received with
respect to the prior Review Dates, the total amount paid, for each $1,000 principal amount note, is $1,075.00.
Example 2 — Notes have NOT been redeemed early
and the Final Value of the Least Performing Index is less than its Interest Barrier but is greater than or equal to its Buffer Threshold.
Date |
Closing Level of Least
Performing Index |
Payment (per $1,000 principal amount note) |
First Review Date |
95.00 |
$6.25 |
Second Review Date |
80.00 |
$6.25 |
Third through Eleventh Review Dates |
Less than Interest Barrier |
$0 |
Final Review Date |
70.00 |
$1,000.00 |
|
Total Payment |
$1,012.50 (1.25% return) |
Because the notes have not been redeemed early and
the Final Value of the Least Performing Index is less than its Interest Barrier but is greater than or equal to its Buffer Threshold,
the payment at maturity, for each $1,000 principal amount note, will be $1,000.00. When added to the Contingent Interest Payments received
with respect to the prior Review Dates, the total amount paid, for each $1,000 principal amount note, is $1,012.50.
PS-5
| Structured Investments
Callable Contingent Interest Notes Linked to the Least Performing
of the S&P 500® Index, the Russell 2000® Value Index and the Russell 1000® Growth Index |
|
Example 3 — Notes have NOT been redeemed early
and the Final Value of the Least Performing Index is less than its Buffer Threshold.
Date |
Closing Level of Least
Performing Index |
Payment (per $1,000 principal amount note) |
First Review Date |
40.00 |
$0 |
Second Review Date |
45.00 |
$0 |
Third through Eleventh Review Dates |
Less than Interest Barrier |
$0 |
Final Review Date |
50.00 |
$714.286 |
|
Total Payment |
$714.286 (-28.5714% return) |
Because the notes have not been redeemed early, the
Final Value of the Least Performing Index is less than its Buffer Threshold and the Least Performing Index Return is -50.00%, the payment
at maturity will be $714.286 per $1,000 principal amount note, calculated as follows:
$1,000 + [$1,000 × (-50.00% + 30.00%) ×
1.42857] = $714.286
The hypothetical returns and hypothetical payments
on the notes shown above apply only if you hold the notes for their entire term. These hypotheticals do not reflect the fees or expenses
that would be associated with any sale in the secondary market. If these fees and expenses were included, the hypothetical returns and
hypothetical payments shown above would likely be lower.
Selected
Risk Considerations
An investment in the notes involves significant risks.
These risks are explained in more detail in the “Risk Factors” sections of the accompanying prospectus supplement, product
supplement and underlying supplement.
Risks Relating to the Notes Generally
| · | YOUR INVESTMENT IN THE NOTES MAY RESULT IN A LOSS — |
The notes do not guarantee any return of principal.
If the notes have not been redeemed early and the Final Value of any Index is less than its Buffer Threshold, you will lose 1.42857% of
the principal amount of your notes for every 1% that the Final Value of the Least Performing Index is less than its Initial Value by more
than 30.00%. Accordingly, under these circumstances, you will lose some or all of your principal amount at maturity.
| · | THE NOTES DO NOT GUARANTEE THE PAYMENT OF INTEREST AND MAY NOT PAY ANY INTEREST AT ALL — |
If the notes have not been redeemed early, we
will make a Contingent Interest Payment with respect to a Review Date (and we will pay you any previously unpaid Contingent Interest Payments
for any prior Review Dates) only if the closing level of each Index on that Review Date is greater than or equal to its Interest Barrier.
If the closing level of any Index on that Review Date is less than its Interest Barrier, no Contingent Interest Payment will be made with
respect to that Review Date. You will not receive any unpaid Contingent Interest Payments if the closing level of the Index on each subsequent
Review Date is less than the Interest Barrier. Accordingly, if the closing level of any Index on each Review Date is less than its Interest
Barrier, you will not receive any interest payments over the term of the notes.
| · | CREDIT RISKS OF JPMORGAN FINANCIAL AND JPMORGAN CHASE & CO. — |
Investors are dependent on our and JPMorgan
Chase & Co.’s ability to pay all amounts due on the notes. Any actual or potential change in our or JPMorgan Chase & Co.’s
creditworthiness or credit spreads, as determined by the market for taking that credit risk, is likely to adversely affect the value of
the notes. If we and JPMorgan Chase & Co. were to default on our payment obligations, you may not receive any amounts owed
to you under the notes and you could lose your entire investment.
| · | AS A FINANCE SUBSIDIARY, JPMORGAN FINANCIAL HAS NO INDEPENDENT OPERATIONS AND HAS LIMITED ASSETS — |
As a finance subsidiary of JPMorgan
Chase & Co., we have no independent operations beyond the issuance and administration of our securities. Aside from
the initial capital contribution from JPMorgan Chase & Co., substantially all of our assets relate to obligations of
our affiliates to make payments under loans made by us or other intercompany agreements. As a result, we are dependent upon payments
from our affiliates to meet our obligations under the notes. If these affiliates do not make payments to us and we fail to make
payments on the notes, you may have to seek payment under the related guarantee by JPMorgan Chase & Co., and that
guarantee will rank pari passu with all other unsecured and unsubordinated obligations of JPMorgan
Chase & Co.
PS-6
| Structured Investments
Callable Contingent Interest Notes Linked to the Least Performing
of the S&P 500® Index, the Russell 2000® Value Index and the Russell 1000® Growth Index |
|
| · | THE APPRECIATION POTENTIAL OF THE NOTES IS LIMITED TO THE SUM OF ANY CONTINGENT INTEREST PAYMENTS THAT MAY BE PAID OVER THE TERM
OF THE NOTES, |
regardless of any appreciation of any Index,
which may be significant. You will not participate in any appreciation of any Index.
| · | YOU ARE EXPOSED TO THE RISK OF DECLINE IN THE LEVEL OF EACH INDEX — |
Payments on the notes are not linked to a basket
composed of the Indices and are contingent upon the performance of each individual Index. Poor performance by any of the Indices over
the term of the notes may negatively affect whether you will receive a Contingent Interest Payment on any Interest Payment Date and your
payment at maturity and will not be offset or mitigated by positive performance by any other Index.
| · | YOUR PAYMENT AT MATURITY WILL BE DETERMINED BY THE LEAST PERFORMING INDEX. |
| · | THE OPTIONAL EARLY REDEMPTION FEATURE MAY FORCE A POTENTIAL EARLY EXIT — |
If we elect to redeem your notes early, the
term of the notes may be reduced to as short as approximately six months and you will not receive any Contingent Interest Payments after
the applicable Interest Payment Date. There is no guarantee that you would be able to reinvest the proceeds from an investment in the
notes at a comparable return and/or with a comparable interest rate for a similar level of risk. Even in cases where we elect to redeem
your notes before maturity, you are not entitled to any fees and commissions described on the front cover of this pricing supplement.
| · | YOU WILL NOT RECEIVE DIVIDENDS ON THE SECURITIES INCLUDED IN ANY INDEX OR HAVE ANY RIGHTS WITH RESPECT TO THOSE SECURITIES. |
| · | THE RISK OF THE CLOSING LEVEL OF AN INDEX FALLING BELOW ITS INTEREST BARRIER OR BUFFER THRESHOLD IS GREATER IF THE LEVEL OF THAT
INDEX IS VOLATILE. |
The notes will not be listed on any securities
exchange. Accordingly, the price at which you may be able to trade your notes is likely to depend on the price, if any, at which JPMS
is willing to buy the notes. You may not be able to sell your notes. The notes are not designed to be short-term trading instruments.
Accordingly, you should be able and willing to hold your notes to maturity.
| · | THE FINAL TERMS AND VALUATION OF THE NOTES WILL BE PROVIDED IN THE PRICING SUPPLEMENT — |
You should consider your potential investment
in the notes based on the minimums for the estimated value of the notes and the Contingent Interest Rate.
Risks Relating to Conflicts of Interest
We and our affiliates play a variety of roles
in connection with the notes. In performing these duties, our and JPMorgan Chase & Co.’s economic interests are potentially
adverse to your interests as an investor in the notes. It is possible that hedging or trading activities of ours or our affiliates in
connection with the notes could result in substantial returns for us or our affiliates while the value of the notes declines. Please refer
to “Risk Factors — Risks Relating to Conflicts of Interest” in the accompanying product supplement.
Risks Relating to the Estimated Value and Secondary
Market Prices of the Notes
| · | THE ESTIMATED VALUE OF THE NOTES WILL BE LOWER THAN THE ORIGINAL ISSUE PRICE (PRICE TO PUBLIC) OF THE NOTES — |
The estimated value of the notes is only an
estimate determined by reference to several factors. The original issue price of the notes will exceed the estimated value of the notes
because costs associated with selling, structuring and hedging the notes are included in the original issue price of the notes. These
costs include the selling commissions, the projected profits, if any, that our affiliates expect to realize for assuming risks inherent
in hedging our obligations under the notes and the estimated cost of hedging our obligations under the notes. See “The Estimated
Value of the Notes” in this pricing supplement.
| · | THE ESTIMATED VALUE OF THE NOTES DOES NOT REPRESENT FUTURE VALUES OF THE NOTES AND MAY DIFFER FROM OTHERS’ ESTIMATES —
|
See “The Estimated Value of the Notes”
in this pricing supplement.
PS-7
| Structured Investments
Callable Contingent Interest Notes Linked to the Least Performing
of the S&P 500® Index, the Russell 2000® Value Index and the Russell 1000® Growth Index |
|
| · | THE ESTIMATED VALUE OF THE NOTES IS DERIVED BY REFERENCE TO AN INTERNAL FUNDING RATE — |
The internal funding rate used in the determination
of the estimated value of the notes may differ from the market-implied funding rate for vanilla fixed income instruments of a similar
maturity issued by JPMorgan Chase & Co. or its affiliates. Any difference may be based on, among other things, our and our
affiliates’ view of the funding value of the notes as well as the higher issuance, operational and ongoing liability management
costs of the notes in comparison to those costs for the conventional fixed income instruments of JPMorgan Chase & Co. This
internal funding rate is based on certain market inputs and assumptions, which may prove to be incorrect, and is intended to approximate
the prevailing market replacement funding rate for the notes. The use of an internal funding rate and any potential changes to that rate
may have an adverse effect on the terms of the notes and any secondary market prices of the notes. See “The Estimated Value of the
Notes” in this pricing supplement.
| · | THE VALUE OF THE NOTES AS PUBLISHED BY JPMS (AND WHICH MAY BE REFLECTED ON CUSTOMER ACCOUNT STATEMENTS) MAY BE HIGHER THAN THE
THEN-CURRENT ESTIMATED VALUE OF THE NOTES FOR A LIMITED TIME PERIOD — |
We generally expect that some of the costs included
in the original issue price of the notes will be partially paid back to you in connection with any repurchases of your notes by JPMS in
an amount that will decline to zero over an initial predetermined period. See “Secondary Market Prices of the Notes” in this
pricing supplement for additional information relating to this initial period. Accordingly, the estimated value of your notes during this
initial period may be lower than the value of the notes as published by JPMS (and which may be shown on your customer account statements).
| · | SECONDARY MARKET PRICES OF THE NOTES WILL LIKELY BE LOWER THAN THE ORIGINAL ISSUE PRICE OF THE NOTES — |
Any secondary market prices of the notes will
likely be lower than the original issue price of the notes because, among other things, secondary market prices take into account our
internal secondary market funding rates for structured debt issuances and, also, because secondary market prices may exclude selling commissions,
projected hedging profits, if any, and estimated hedging costs that are included in the original issue price of the notes. As a result,
the price, if any, at which JPMS will be willing to buy the notes from you in secondary market transactions, if at all, is likely to be
lower than the original issue price. Any sale by you prior to the Maturity Date could result in a substantial loss to you.
| · | SECONDARY MARKET PRICES OF THE NOTES WILL BE IMPACTED BY MANY ECONOMIC AND MARKET FACTORS — |
The secondary market price of the notes during
their term will be impacted by a number of economic and market factors, which may either offset or magnify each other, aside from the
selling commissions, projected hedging profits, if any, estimated hedging costs and the levels of the Indices. Additionally, independent
pricing vendors and/or third party broker-dealers may publish a price for the notes, which may also be reflected on customer account statements.
This price may be different (higher or lower) than the price of the notes, if any, at which JPMS may be willing to purchase your notes
in the secondary market. See “Risk Factors — Risks Relating to the Estimated Value and Secondary Market Prices of the Notes
— Secondary market prices of the notes will be impacted by many economic and market factors” in the accompanying product supplement.
Risks Relating to the Indices
| · | JPMORGAN CHASE & CO. IS CURRENTLY ONE OF THE COMPANIES THAT MAKE UP THE S&P 500® INDEX, |
but JPMorgan Chase & Co. will
not have any obligation to consider your interests in taking any corporate action that might affect the level of the S&P 500®
Index.
| · | AN INVESTMENT IN THE NOTES IS SUBJECT TO RISKS ASSOCIATED WITH SMALL CAPITALIZATION STOCKS WITH RESPECT TO THE RUSSELL 2000®
VALUE INDEX — |
Small capitalization companies may be less able
to withstand adverse economic, market, trade and competitive conditions relative to larger companies. Small capitalization companies are
less likely to pay dividends on their stocks, and the presence of a dividend payment could be a factor that limits downward stock price
pressure under adverse market conditions.
| · | THE INVESTMENT STRATEGIES REPRESENTED BY THE RUSSELL 2000® VALUE INDEX
AND THE RUSSELL 1000® GROWTH INDEX MAY NOT BE SUCCESSFUL — |
The
Russell 2000® Value Index measures the capitalization-weighted price performance of the stocks included in the
Russell 2000® Index that are determined by FTSE Russell to be value oriented, with lower price-to-book ratios and
lower forecasted and historical growth. The Russell 1000® Growth Index measures the capitalization-weighted price
performance of the stocks included in the Russell 1000® Index that are determined by FTSE Russell to be growth
oriented, with higher price-to-book ratios and higher forecasted and historical growth. However, the value characteristics
referenced by the selection methodology of the Russell 2000® Value Index may not be accurate predictors of
undervalued stocks, and the growth characteristics referenced by the selection
PS-8
| Structured Investments
Callable Contingent Interest Notes Linked to the Least Performing
of the S&P 500® Index, the Russell 2000® Value Index and the Russell 1000® Growth Index |
|
methodology of the Russell 1000® Growth
Index may not be accurate predictors of stocks with strong growth potential. In addition, the selection methodology of the Russell 2000®
Value Index includes a significant bias against stocks with strong growth characteristics, and the selection methodology of the Russell
1000® Growth Index includes a significant bias against stocks with strong value characteristics. There is no assurance
that the Russell 2000® Value Index will be more representative of “value” stocks than any other index or strategy
that seeks to track “value” stocks selected using other criteria, and there is no assurance that the Russell 1000®
Growth Index will be more representative of “growth” stocks than any other index or strategy that seeks to track “growth”
stocks selected using other criteria.
There
can also be no assurance that a “value” investment strategy or a “growth” investment strategy will be successful
at any time. A “value” investment strategy is premised on the goal of investing in stocks that are determined to be relatively
cheap or “undervalued” under the assumption that the value of those stocks will increase over time as the market comes to
recognize and reflect the “fair” market value of those stocks. However, stocks that are considered value stocks may fail to
appreciate for extended periods of time, and may never realize their full potential value. A “growth” investment strategy
is premised on the goal of investing in stocks that may experience above-market growth. Growth stocks may be subject to higher volatility
than other investments and may involve greater risk than other stocks. There can be no assurance that stocks that have exhibited growth
in the past will continue to exhibit growth in the future.
The Russell
2000® Value Index may underperform the Russell 2000® Index as a whole, and the Russell 1000®
Growth Index may underperform the Russell 1000® Index as a whole. It is possible that the stock selection methodologies
of the Russell 2000® Value Index and the Russell 1000® Growth Index will adversely affect their respective
returns and, consequently, the value and return of the notes.
PS-9
| Structured Investments
Callable Contingent Interest Notes Linked to the Least Performing
of the S&P 500® Index, the Russell 2000® Value Index and the Russell 1000® Growth Index |
|
The Indices
The S&P 500® Index consists of stocks
of 500 companies selected to provide a performance benchmark for the U.S. equity markets. For additional information about the S&P
500® Index, see “Equity Index Descriptions — The S&P U.S. Indices” in the accompanying underlying
supplement.
The Russell 2000® Value Index measures
the capitalization-weighted price performance of the stocks included in the Russell 2000® Index that are determined by
FTSE Russell to be value oriented, with lower price-to-book ratios and lower forecasted and historical growth. The Russell 2000®
Index consists of the middle 2,000 companies included in the Russell 3000E™ Index and, as a result of the index calculation methodology,
consists of the smallest 2,000 companies included in the Russell 3000® Index. The Russell 2000® Index is
designed to track the performance of the small capitalization segment of the U.S. equity market. For additional information about the
Russell 2000® Value Index, see Annex A in this pricing supplement.
The Russell 1000® Growth Index measures
the capitalization-weighted price performance of the stocks included in the Russell 1000® Index that are determined by
FTSE Russell to be growth oriented, with higher price-to-book ratios and higher forecasted and historical growth. The Russell 1000®
Index measures the capitalization-weighted price performance of 1,000 U.S. large-capitalization stocks listed on eligible U.S. exchanges.
For additional information about the Russell 1000® Growth Index, see Annex A in this pricing supplement.
Historical Information
The following graphs set forth the historical performance
of each Index based on the weekly historical closing levels from January 5, 2018 through March 10, 2023. The closing level of the S&P
500® Index on March 16, 2023 was 3,960.28. The closing level of the Russell 2000® Value Index on March 16,
2023 was 2,043.567. The closing level of the Russell 1000® Growth Index on March 16, 2023 was 2,359.506. We obtained the
closing levels above and below from the Bloomberg Professional® service (“Bloomberg”), without independent
verification.
The historical closing levels of each Index should
not be taken as an indication of future performance, and no assurance can be given as to the closing level of any Index on the Pricing
Date or any Review Date. There can be no assurance that the performance of the Indices will result in the return of any of your principal
amount or the payment of any interest.
PS-10
| Structured Investments
Callable Contingent Interest Notes Linked to the Least Performing
of the S&P 500® Index, the Russell 2000® Value Index and the Russell 1000® Growth Index |
|
Tax Treatment
You should review carefully the section entitled
“Material U.S. Federal Income Tax Consequences” in the accompanying product supplement no. 4-II. In determining our reporting
responsibilities we intend to treat (i) the notes for U.S. federal income tax purposes as prepaid forward contracts with associated contingent
coupons and (ii) any Contingent Interest Payments as ordinary income, as described in the section entitled “Material U.S. Federal
Income Tax Consequences — Tax Consequences to U.S. Holders — Notes Treated as Prepaid Forward Contracts with Associated Contingent
Coupons” in the accompanying product supplement. Based on the advice of Davis Polk & Wardwell LLP, our special tax counsel,
we believe that this is a reasonable treatment, but that there are other reasonable treatments that the IRS or a court may adopt, in which
case the timing and character of any income or loss on the notes could be materially affected. In addition, in 2007 Treasury and the IRS
released a notice requesting comments on the U.S. federal income tax treatment of “prepaid forward contracts” and similar
instruments. The notice focuses in particular on whether to require investors in these instruments to accrue income over the term of their
investment. It also asks for comments on a number of related topics, including the character of income or loss with respect to these instruments
and the relevance of factors such as the nature of the underlying property to which the instruments are linked. While the notice requests
comments on appropriate transition rules and effective dates, any Treasury regulations or other guidance promulgated after consideration
of these issues could materially affect the tax consequences of an investment in the notes, possibly with retroactive effect. The discussions
above and in the accompanying product supplement do not address the consequences to taxpayers subject to special tax accounting rules
under Section 451(b) of the Code. You should consult your tax adviser regarding the U.S. federal income tax consequences of an investment
in the notes, including possible alternative treatments and the issues presented by the notice described above.
PS-11
| Structured Investments
Callable Contingent Interest Notes Linked to the Least Performing
of the S&P 500® Index, the Russell 2000® Value Index and the Russell 1000® Growth Index |
|
Non-U.S. Holders
— Tax Considerations. The U.S. federal income tax treatment of Contingent Interest Payments is uncertain, and although we believe
it is reasonable to take a position that Contingent Interest Payments are not subject to U.S. withholding tax (at least if an applicable
Form W-8 is provided), it is expected that withholding agents will (and we, if we are the withholding agent, intend to) withhold on any
Contingent Interest Payment paid to a Non-U.S. Holder generally at a rate of 30% or at a reduced rate specified by an applicable income
tax treaty under an “other income” or similar provision. We will not be required to pay any additional amounts with respect
to amounts withheld. In order to claim an exemption from, or a reduction in, the 30% withholding tax, a Non-U.S. Holder of the notes must
comply with certification requirements to establish that it is not a U.S. person and is eligible for such an exemption or reduction under
an applicable tax treaty. If you are a Non-U.S. Holder, you should consult your tax adviser regarding the tax treatment of the notes,
including the possibility of obtaining a refund of any withholding tax and the certification requirement described above.
Section 871(m) of the Code and Treasury regulations
promulgated thereunder (“Section 871(m)”) generally impose a 30% withholding tax (unless an income tax treaty applies) on
dividend equivalents paid or deemed paid to Non-U.S. Holders with respect to certain financial instruments linked to U.S. equities or
indices that include U.S. equities. Section 871(m) provides certain exceptions to this withholding regime, including for instruments linked
to certain broad-based indices that meet requirements set forth in the applicable Treasury regulations. Additionally, a recent IRS notice
excludes from the scope of Section 871(m) instruments issued prior to January 1, 2025 that do not have a delta of one with respect to
underlying securities that could pay U.S.-source dividends for U.S. federal income tax purposes (each an “Underlying Security”).
Based on certain determinations made by us, we expect that Section 871(m) will not apply to the notes with regard to Non-U.S. Holders.
Our determination is not binding on the IRS, and the IRS may disagree with this determination. Section 871(m) is complex and its application
may depend on your particular circumstances, including whether you enter into other transactions with respect to an Underlying Security.
If necessary, further information regarding the potential application of Section 871(m) will be provided in the pricing supplement for
the notes. You should consult your tax adviser regarding the potential application of Section 871(m) to the notes.
In the event of any
withholding on the notes, we will not be required to pay any additional amounts with respect to amounts so withheld.
The Estimated Value of the Notes
The estimated value of the notes set forth on the
cover of this pricing supplement is equal to the sum of the values of the following hypothetical components: (1) a fixed-income debt component
with the same maturity as the notes, valued using the internal funding rate described below, and (2) the derivative or derivatives underlying
the economic terms of the notes. The estimated value of the notes does not represent a minimum price at which JPMS would be willing to
buy your notes in any secondary market (if any exists) at any time. The internal funding rate used in the determination of the estimated
value of the notes may differ from the market-implied funding rate for vanilla fixed income instruments of a similar maturity issued by
JPMorgan Chase & Co. or its affiliates. Any difference may be based on, among other things, our and our affiliates’
view of the funding value of the notes as well as the higher issuance, operational and ongoing liability management costs of the notes
in comparison to those costs for the conventional fixed income instruments of JPMorgan Chase & Co. This internal funding
rate is based on certain market inputs and assumptions, which may prove to be incorrect, and is intended to approximate the prevailing
market replacement funding rate for the notes. The use of an internal funding rate and any potential changes to that rate may have an
adverse effect on the terms of the notes and any secondary market prices of the notes. For additional information, see “Selected
Risk Considerations — Risks Relating to the Estimated Value and Secondary Market Prices of the Notes — The Estimated Value
of the Notes Is Derived by Reference to an Internal Funding Rate” in this pricing supplement.
The value of the derivative or derivatives underlying
the economic terms of the notes is derived from internal pricing models of our affiliates. These models are dependent on inputs such as
the traded market prices of comparable derivative instruments and on various other inputs, some of which are market-observable, and which
can include volatility, dividend rates, interest rates and other factors, as well as assumptions about future market events and/or environments.
Accordingly, the estimated value of the notes is determined when the terms of the notes are set based on market conditions and other relevant
factors and assumptions existing at that time.
The estimated value of the notes does not represent
future values of the notes and may differ from others’ estimates. Different pricing models and assumptions could provide valuations
for the notes that are greater than or less than the estimated value of the notes. In addition, market conditions and other relevant factors
in the future may change, and any assumptions may prove to be incorrect. On future dates, the value of the notes could change significantly
based on, among other things, changes in market conditions, our or JPMorgan Chase & Co.’s creditworthiness, interest
rate movements and other relevant factors, which may impact the price, if any, at which JPMS would be willing to buy notes from you in
secondary market transactions.
The estimated value of the notes will be lower than
the original issue price of the notes because costs associated with selling, structuring and hedging the notes are included in the original
issue price of the notes. These costs include the selling commissions paid to JPMS and other affiliated or unaffiliated dealers, the projected
profits, if any, that our affiliates expect to realize for assuming
PS-12
| Structured Investments
Callable Contingent Interest Notes Linked to the Least Performing
of the S&P 500® Index, the Russell 2000® Value Index and the Russell 1000® Growth Index |
|
risks inherent in hedging our obligations under the notes and the estimated
cost of hedging our obligations under the notes. Because hedging our obligations entails risk and may be influenced by market forces beyond
our control, this hedging may result in a profit that is more or less than expected, or it may result in a loss. A portion of the profits,
if any, realized in hedging our obligations under the notes may be allowed to other affiliated or unaffiliated dealers, and we or one
or more of our affiliates will retain any remaining hedging profits. See “Selected Risk Considerations — Risks Relating to
the Estimated Value and Secondary Market Prices of the Notes — The Estimated Value of the Notes Will Be Lower Than the Original
Issue Price (Price to Public) of the Notes” in this pricing supplement.
Secondary
Market Prices of the Notes
For information about factors that will impact any
secondary market prices of the notes, see “Risk Factors — Risks Relating to the Estimated Value and Secondary Market Prices
of the Notes — Secondary market prices of the notes will be impacted by many economic and market factors” in the accompanying
product supplement. In addition, we generally expect that some of the costs included in the original issue price of the notes will be
partially paid back to you in connection with any repurchases of your notes by JPMS in an amount that will decline to zero over an initial
predetermined period. These costs can include selling commissions, projected hedging profits, if any, and, in some circumstances, estimated
hedging costs and our internal secondary market funding rates for structured debt issuances. This initial predetermined time period is
intended to be the shorter of six months and one-half of the stated term of the notes. The length of any such initial period reflects
the structure of the notes, whether our affiliates expect to earn a profit in connection with our hedging activities, the estimated costs
of hedging the notes and when these costs are incurred, as determined by our affiliates. See “Selected Risk Considerations —
Risks Relating to the Estimated Value and Secondary Market Prices of the Notes — The Value of the Notes as Published by JPMS (and
Which May Be Reflected on Customer Account Statements) May Be Higher Than the Then-Current Estimated Value of the Notes for a Limited
Time Period” in this pricing supplement.
Supplemental
Use of Proceeds
The notes are offered to meet investor demand for products
that reflect the risk-return profile and market exposure provided by the notes. See “How the Notes Work” and “Hypothetical
Payout Examples” in this pricing supplement for an illustration of the risk-return profile of the notes and “The Indices”
in this pricing supplement for a description of the market exposure provided by the notes.
The original issue price of the notes is equal to the
estimated value of the notes plus the selling commissions paid to JPMS and other affiliated or unaffiliated dealers, plus (minus) the
projected profits (losses) that our affiliates expect to realize for assuming risks inherent in hedging our obligations under the notes,
plus the estimated cost of hedging our obligations under the notes.
Supplemental
Plan of Distribution
We expect that delivery of the notes will be made against
payment for the notes on or about the Original Issue Date set forth on the front cover of this pricing supplement, which will be the third
business day following the Pricing Date of the notes (this settlement cycle being referred to as “T+3”). Under Rule 15c6-1
of the Securities Exchange Act of 1934, as amended, trades in the secondary market generally are required to settle in two business days,
unless the parties to that trade expressly agree otherwise. Accordingly, purchasers who wish to trade notes on any date prior to two business
days before delivery will be required to specify an alternate settlement cycle at the time of any such trade to prevent a failed settlement
and should consult their own advisors.
Supplemental
Information About the Form of the Notes
The notes will initially be represented by a type of
global security that we refer to as a master note. A master note represents multiple securities that may be issued at different
times and that may have different terms. The trustee and/or paying agent will, in accordance with instructions from us, make appropriate
entries or notations in its records relating to the master note representing the notes to indicate that the master note evidences the
notes.
Additional
Terms Specific to the Notes
You may revoke your offer to purchase the notes at
any time prior to the time at which we accept such offer by notifying the applicable agent. We reserve the right to change the terms of,
or reject any offer to purchase, the notes prior to their issuance. In the event of any changes to the terms of the notes, we will notify
you and you will be asked to accept such changes in connection with your purchase. You may also choose to reject such changes, in which
case we may reject your offer to purchase.
You should read this pricing supplement together with
the accompanying prospectus, as supplemented by the accompanying prospectus supplement relating to our Series A medium-term notes of which
these notes are a part, and the more detailed information contained in the accompanying product supplement and the accompanying underlying
supplement. This pricing supplement, together with the documents listed below, contains the terms of the notes and supersedes all other
prior or contemporaneous oral statements as well as any other written materials including preliminary or indicative pricing terms, correspondence,
trade ideas, structures for implementation, sample structures, fact sheets, brochures or other educational materials of ours. You should
carefully consider, among other things, the matters set forth in the “Risk Factors” sections of the accompanying prospectus
supplement, the accompanying
PS-13
| Structured Investments
Callable Contingent Interest Notes Linked to the Least Performing
of the S&P 500® Index, the Russell 2000® Value Index and the Russell 1000® Growth Index |
|
product supplement and the accompanying underlying supplement, as the
notes involve risks not associated with conventional debt securities. We urge you to consult your investment, legal, tax, accounting and
other advisers before you invest in the notes.
You may access these documents on the SEC website at
www.sec.gov as follows (or if such address has changed, by reviewing our filings for the relevant date on the SEC website):
Our Central Index Key, or CIK, on the SEC website is
1665650, and JPMorgan Chase & Co.’s CIK is 19617. As used in this pricing supplement, “we,” “us”
and “our” refer to JPMorgan Financial.
PS-14
| Structured Investments
Callable Contingent Interest Notes Linked to the Least Performing
of the S&P 500® Index, the Russell 2000® Value Index and the Russell 1000® Growth Index |
|
Annex
A
The Russell
Style Indices
All information contained in
this pricing supplement regarding the Russell 1000® Growth Index and the Russell 2000® Growth
Index (each, a “Russell Growth Index” and collectively, the “Russell Growth Indices”) and the Russell 1000® Value
Index and the Russell 2000® Value Index (each, a “Russell Value Index” and collectively, the “Russell
Value Indices”), including, without limitation, their make-up, method of calculation and changes in their components, has been derived
from publicly available information, without independent verification. This information reflects the policies of, and is subject to change
by, FTSE Russell (“FTSE”), which is wholly owned by the London Stock Exchange Group. The Russell Growth Indices and the Russell
Value Indices (each, a “Russell Style Index” and collectively, the “Russell Style Indices”) are calculated, maintained
and published by FTSE. FTSE has no obligation to continue to publish, and may discontinue publication of, any of the Russell Style Indices.
The constituents included in
each Russell Style Index are members of the Russell 1000® Index or the Russell 2000® Index (each,
a “Russell Index” and collectively, the “Russell Indices”), as applicable. The Russell 1000® Index
measures the capitalization-weighted price performance of 1,000 large-capitalization stocks (with respect to the Russell 1000® Index,
the “Component Stocks”) and is designed to track the performance of the large-capitalization segment of the U.S. equity market.
The Russell 2000® Index measures the capitalization-weighted price performance of 2,000 small-capitalization stocks
(with respect to the Russell 2000® Index, the “Component Stocks”) and is designed to track the performance
of the small-capitalization segment of the U.S. equity market. For additional information about the Russell Indices, please see “—
The Russell Indices” in the accompanying underlying supplement.
The Russell 1000® Growth
Index
The Russell 1000® Growth
Index measures the capitalization-weighted price performance of the stocks included in the Russell 1000® Index that
are determined by FTSE to be growth oriented, with higher price-to-book ratios and higher forecasted and historical growth. The Russell
1000® Growth Index is reported by Bloomberg L.P. under the ticker symbol “RLG.”
The Russell 2000® Value
Index
The Russell 2000® Value
Index measures the capitalization-weighted price performance of the stocks included in the Russell 2000® Index that
are determined by FTSE to be value oriented, with lower price-to-book ratios and lower forecasted and historical growth. The Russell 2000® Value
Index is reported by Bloomberg L.P. under the ticker symbol “RUJ.”
Determining Style
FTSE uses a “non-linear
probability” method to assign stocks to a Russell Value Index, an index that measures the capitalization-weighted price performance
of the relevant Component Stocks determined by FTSE to be value oriented, with lower price-to-book ratios and lower forecasted and historical
growth, and a Russell Growth Index, an index that measures the capitalization-weighted price performance of the relevant Component Stocks
determined by FTSE to be growth oriented, with higher price-to-book ratios and higher forecasted and historical growth.
FTSE uses three variables in
the determination of value and growth. For value, book-to-price (B/P) ratio is used, while for growth, two variables — I/B/E/S forecast
medium-term growth (2-year) and sales per share historical growth (5-year) — are used. The term “probability” is used
to indicate the degree of certainty that a stock is value or growth based on its relative book-to-price (B/P) ratio, I/B/E/S forecast
medium-term growth (2 year) and sales per share historical growth (5 year).
First, the relevant Component
Stocks are ranked by their adjusted book-to-price ratio (B/P), their I/B/E/S forecast medium-term growth (2 year) and sales per share
historical growth (5 year). These rankings are then converted to standardized units, where the value variable represents 50% of the score
and the two growth variables represent the remaining 50%. Next, these units are combined to produce a composite value score (“CVS”).
The relevant Component Stocks
are then ranked by their CVS, and a probability algorithm is applied to the CVS distribution to assign growth and value weights to each
stock. In general, a stock with a lower CVS is considered growth, a stock with a higher CVS is considered value and a stock with a CVS
in the middle range is considered to have both growth and value characteristics, and is weighted proportionately in the relevant Russell
Growth Index and the corresponding Russell Value Index. Stocks are always fully represented by the combination of their growth and value
weights (e.g., a stock that is given a 20% weight in a Russell Value Index will have an 80% weight in the corresponding Russell
Growth Index). Style index assignment for non-pricing vehicle share classes will be based on that of the pricing vehicle and assigned
consistently across all additional share classes.
Stock A, in the figure below,
is a security with 20% of its available shares assigned to a Russell Value Index and the remaining 80% assigned to the corresponding Russell
Growth Index. The growth and value probabilities will always sum to 100%. Hence, the sum of a stock’s market capitalization in a
Russell Growth Index and the corresponding Russell Value Index will always equal its market capitalization in the relevant Russell Index.
PS-15
| Structured Investments
Callable Contingent Interest Notes Linked to the Least Performing
of the S&P 500® Index, the Russell 2000® Value Index and the Russell 1000® Growth Index |
|
In the figure above, the quartile
breaks are calculated such that approximately 25% of the available market capitalization lies in each quartile. Stocks at the median are
divided 50% in each of the relevant Russell Growth Index and the corresponding Russell Value Index. Stocks below the first quartile are
100% in the Russell Growth Index. Stocks above the third quartile are 100% in the relevant Russell Value Index. Stocks falling between
the first and third quartile breaks are included in both the relevant Russell Growth Index and the corresponding Russell Value Index to
varying degrees, depending on how far they are above or below the median and how close they are to the first or third quartile breaks.
Roughly 70% of the available
market capitalization is classified as all growth or all value. The remaining 30% have some portion of their market value in either the
relevant Russell Value Index or the corresponding Russell Growth Index, depending on their relative distance from the median value score.
Note that there is a small position cutoff rule. If a stock’s weight is more than 95% in one Russell Style Index, its weight is
increased to 100% in that Russell Style Index.
In an effort to mitigate unnecessary
turnover, FTSE implements a banding methodology at the CVS level of the growth and value style algorithm. If a company’s CVS change
from the previous year is less than or equal to +/- 0.10 and if the company remains in the relevant Russell Index, then the CVS remains
unchanged during the next reconstitution process. Keeping the CVS static for these companies does not mean the probability (growth/value)
will remain unchanged in all cases due to the relation of a CVS score to the overall Russell Style Index. However, this banding methodology
is intended to reduce turnover caused by smaller, less meaningful movements while continuing to allow the larger, more meaningful changes
to occur, signaling a true change in a company’s relation to the market.
In calculating growth and value
weights, stocks with missing or negative values for B/P, or missing values for I/B/E/S growth (negative I/B/E/S growth is valid), or missing
sales per share historical growth (6 years of quarterly numbers are required), are allocated by using the mean value score of the Industry
Classification Benchmark subsector, sector, supersector or industry group of the relevant Russell Index into which the company falls.
Each missing (or negative B/P) variable is substituted with the subsector, sector, supersector or industry group independently. An industry
must have five members or the substitution reverts to the subsector and so forth to the sector. In addition, a weighted value score is
calculated for securities with low analyst coverage for I/B/E/S medium-term growth. For securities with coverage by a single analyst,
2/3 of the subsector, sector, supersector or industry group value score is weighted with 1/3 the security’s independent value score.
For those securities with coverage by two analysts, 2/3 of the independent security’s value score is used and only 1/3 of the subsector,
sector, supersector or industry group is weighted. For those securities with at least three analysts contributing to the I/B/E/S medium-term
growth, 100% of the independent security’s value score is used.
Disclaimers
The notes are not sponsored,
endorsed, sold, or promoted by London Stock Exchange Group plc or its affiliates (collectively, “LSE”) or any successor thereto
or index owner and neither LSE nor any party hereto makes any representation or warranty whatsoever, whether express or implied, to the
owners of the notes or any member of the public regarding the advisability of investing in securities generally or in the notes particularly
or the ability of the Russell Style Indices to track general stock market performance or a segment of the same. LSE’s publication
of the Russell Style Indices in no way suggests or implies an opinion by LSE as to the advisability of investment in any or all of the
securities upon which the Russell Style Indices are based. LSE’s only relationship to JPMorgan Financial, JPMorgan Chase & Co.
and their affiliates is the licensing of certain trademarks and trade names of LSE and of the Russell Style Indices, which are determined,
composed and calculated by LSE without regard to JPMorgan Financial, JPMorgan Chase & Co. and their affiliates or the notes.
LSE is not responsible for and has not reviewed the notes or any associated literature or publications and LSE makes no representation
or warranty express or implied as to their accuracy or completeness, or otherwise. LSE reserves the
PS-16
| Structured Investments
Callable Contingent Interest Notes Linked to the Least Performing
of the S&P 500® Index, the Russell 2000® Value Index and the Russell 1000® Growth Index |
|
right, at any time and without notice, to alter, amend, terminate or
in any way change the Russell Style Indices. LSE has no obligation or liability in connection with the administration, marketing
or trading of the notes.
“Russell 2000®
Value Index,” “Russell 1000® Growth Index” and “Russell 1000® Index” are trademarks
of LSE and have been licensed for use by JPMorgan Chase Bank, National Association and its affiliates. This transaction is not sponsored,
endorsed, sold, or promoted by LSE and LSE makes no representation regarding the advisability of entering into this transaction.
LSE DOES NOT GUARANTEE THE
ACCURACY AND/OR THE COMPLETENESS OF THE RUSSELL STYLE INDICES OR ANY DATA INCLUDED THEREIN AND LSE SHALL HAVE NO LIABILITY FOR ANY ERRORS,
OMISSIONS, OR INTERRUPTIONS THEREIN. LSE MAKES NO WARRANTY, EXPRESS OR IMPLIED, AS TO RESULTS TO BE OBTAINED BY JPMORGAN FINANCIAL, JPMORGAN
CHASE & CO. AND/OR THEIR AFFILIATES, INVESTORS, OWNERS OF THE PRODUCT(S), OR ANY OTHER PERSON OR ENTITY FROM THE USE OF
THE RUSSELL STYLE INDICES OR ANY DATA INCLUDED THEREIN. LSE MAKES NO EXPRESS OR IMPLIED WARRANTIES, AND EXPRESSLY DISCLAIMS ALL WARRANTIES
OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE OR USE WITH RESPECT TO THE RUSSELL STYLE INDICES OR ANY DATA INCLUDED THEREIN.
WITHOUT LIMITING ANY OF THE FOREGOING, IN NO EVENT SHALL LSE HAVE ANY LIABILITY FOR ANY SPECIAL, PUNITIVE, INDIRECT, OR CONSEQUENTIAL
DAMAGES (INCLUDING LOST PROFITS), EVEN IF NOTIFIED OF THE POSSIBILITY OF SUCH DAMAGES.
PS-17
| Structured Investments
Callable Contingent Interest Notes Linked to the Least Performing
of the S&P 500® Index, the Russell 2000® Value Index and the Russell 1000® Growth Index |
|
JP Morgan Chase (NYSE:JPM)
Historical Stock Chart
Von Mär 2024 bis Apr 2024
JP Morgan Chase (NYSE:JPM)
Historical Stock Chart
Von Apr 2023 bis Apr 2024